G MICHAEL LOPEZ

Allopathic & Osteopathic Physicians|Internal Medicine LAS VEGAS, NM NPI 1003973397

General Payments — all program years on this page

$5,011.06

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 253
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $408.46 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $408.4614

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $134.657
Phathom Pharmaceuticals, Inc. $125.001
ITI, Inc. $65.031
Novo Nordisk AS $30.552
Bayer HealthCare Pharmaceuticals Inc. $21.811
Lilly USA, LLC $15.731
CVRx Inc. $15.691

By program year

Program yearAmountRecords
2018 $794.3832
2019 $445.4221
2020 $760.7949
2021 $1,305.7077
2022 $953.8243
2023 $342.4917
2024 $408.4614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086192802 Bayer Healthcare Pharmaceuticals Inc. $21.81 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096659333 Novo Nordisk Inc $17.43 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096904213 Novo Nordisk Inc $13.12 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104460896 AstraZeneca Pharmaceuticals LP $20.18 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104483478 AstraZeneca Pharmaceuticals LP $16.78 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104594294 AstraZeneca Pharmaceuticals LP $24.36 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104737281 AstraZeneca Pharmaceuticals LP $20.18 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104771976 AstraZeneca Pharmaceuticals LP $22.96 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105274328 AstraZeneca Pharmaceuticals LP $21.07 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105677561 AstraZeneca Pharmaceuticals LP $9.12 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133234972 CVRx, Inc. $15.69 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134976998 Lilly USA, LLC $15.73 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143266894 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $65.03 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151090289 Phathom Pharmaceuticals, Inc. $125.00 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.